Teladoc Health, Inc. (TDOC) Quick Ratio (Acid-Test): 2.59
Is Teladoc Health, Inc.’s quick ratio (acid-test) high or low?
Teladoc Health, Inc.'s quick ratio (acid-test) of 2.59 is 10% below its 5-year average of 2.89, around the middle of its 5-year range (1.73–3.48).
As of Tuesday, June 23, 2026. 19.91% above its 12-month average of 2.16.
TDOC Quick Ratio (Acid-Test) Chart
TDOC Average Quick Ratio (Acid-Test) Chart
TDOC Current vs Average Quick Ratio (Acid-Test) Chart
TDOC Quick Ratio (Acid-Test) Metrics
QUICK RATIO (ACID-TEST)
2.59
QUICK RATIO (ACID-TEST) AVG TTM
2.16
QUICK RATIO (ACID-TEST) AVG 3Y
2.71
QUICK RATIO (ACID-TEST) AVG 5Y
2.89
QUICK RATIO (ACID-TEST) AVG 10Y
4.42
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.91%
CURRENT VS 3Y AVG
-4.60%
CURRENT VS 5Y AVG
-10.48%
CURRENT VS 10Y AVG
-41.43%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TDOC Competitors' Quick Ratio (Acid-Test)
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.37B | 2.59 | 2.16 | 2.71 | 2.89 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.03B | 1.03 | 0.89 | 0.95 | 0.97 |
| Shoulder Innovations, Inc. (SI)vs › | $366.44M | -17.44 | 5.81 | 5.81 | 5.81 |
| TransMedics Group, Inc. (TMDX)vs › | $2.61B | 6.59 | 7.05 | 8.10 | 8.04 |
| 23andMe Holding Co. (ME)vs › | $15.31M | 0.70 | 1.29 | 2.30 | 2.23 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.48B | 1.61 | 1.56 | 2.48 | 3.39 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.60B | 4.19 | 4.52 | 4.42 | 3.69 |
| Oscar Health, Inc. (OSCR)vs › | $7.63B | 0.95 | 0.93 | 1.04 | 1.20 |
| Tempus AI, Inc. (TEM)vs › | $8.35B | 3.00 | 2.58 | 2.23 | 3.05 |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.75B | 1.02 | 1.07 | 1.10 | 1.11 |
Liquidity Comparison
Quick Ratio
2.59
Excludes inventory
Current Ratio
2.69
Includes inventory
Teladoc Health, Inc. Quick Ratio (Acid-Test) Formula & Definition
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Teladoc Health, Inc. Quick Ratio (Acid-Test) FAQ
- What is the quick ratio (acid-test) for Teladoc Health, Inc. (TDOC)?
- The quick ratio (acid-test) for TDOC stock is 2.59.
- Is Teladoc Health, Inc.'s quick ratio (acid-test) high or low?
- Teladoc Health, Inc.'s quick ratio (acid-test) of 2.59 is 10% below its 5-year average of 2.89, around the middle of its 5-year range (1.73–3.48).
- What is the TTM average quick ratio (acid-test) for Teladoc Health, Inc. (TDOC)?
- The TTM average quick ratio (acid-test) for TDOC stock is 2.16.
- What is the 3Y average quick ratio (acid-test) for Teladoc Health, Inc. (TDOC)?
- The 3Y average quick ratio (acid-test) for TDOC stock is 2.71.
- What is the 5Y average quick ratio (acid-test) for Teladoc Health, Inc. (TDOC)?
- The 5Y average quick ratio (acid-test) for TDOC stock is 2.89.
- What is the 10Y average quick ratio (acid-test) for Teladoc Health, Inc. (TDOC)?
- The 10Y average quick ratio (acid-test) for TDOC stock is 4.42.
Teladoc Health, Inc. Quick Ratio (Acid-Test) History
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 2.59 |
| 2024-12-31 | 1.73 |
| 2023-12-31 | 3.47 |
| 2022-12-31 | 3.07 |
| 2021-12-31 | 3.48 |
| 2020-12-31 | 3.02 |
| 2019-12-31 | 6.52 |
| 2018-12-31 | 8.53 |
| 2017-12-31 | 3.87 |
| 2016-12-31 | 3.93 |
| 2015-12-31 | 8.43 |
| 2014-12-31 | 4.20 |
| 2013-12-31 | 1.33 |
Related Metrics
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita